{"id":140825,"date":"2026-07-06T14:07:45","date_gmt":"2026-07-06T08:37:45","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=140825"},"modified":"2026-07-06T14:07:46","modified_gmt":"2026-07-06T08:37:46","slug":"rubicon-research-share-price-usfda-observations-pithampur","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-usfda-observations-pithampur\/","title":{"rendered":"Rubicon Research Share Price Rises Despite USFDA Issuing Two Observations for Pithampur Plant"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Rubicon Research share price CMP Rs 1,370.80, up 5.22%. USFDA issued Form 483 with two observations after unannounced Pithampur plant inspection, 29 June to 3 July 2026.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/user\/stocks\/rubicon\/rubicon-research-limited-share-price-today\">Rubicon Research<\/a> share price rose 5.22 percent to Rs 1,370.80 on 6 July 2026 even after the United States Food and Drug Administration issued two observations following an unannounced inspection of the company&#8217;s manufacturing facility at Pithampur, Madhya Pradesh. The inspection was conducted between 29 June and 3 July 2026.<\/p>\n<p>Following the inspection, the US health regulator issued Form 483 to the company, a standard notification listing observations that inspectors believe may constitute violations, though the stock&#8217;s positive reaction suggests investors view the two observations as manageable rather than serious.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=rubicon-research-share-price-usfda-observations\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-usfda-observations-pithampur\/#About_Rubicon_Research\" title=\"About Rubicon Research\">About Rubicon Research<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-usfda-observations-pithampur\/#Why_Rubicon_Research_Share_Price_Is_in_Focus_Today\" title=\"Why Rubicon Research Share Price Is in Focus Today\">Why Rubicon Research Share Price Is in Focus Today<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-usfda-observations-pithampur\/#Details_of_the_USFDA_Inspection\" title=\"Details of the USFDA Inspection\">Details of the USFDA Inspection<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-usfda-observations-pithampur\/#Form_483_With_Two_Observations\" title=\"Form 483 With Two Observations\">Form 483 With Two Observations<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-usfda-observations-pithampur\/#Rubicon_Research_USFDA_Inspection_Details\" title=\"Rubicon Research USFDA Inspection Details\">Rubicon Research USFDA Inspection Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-usfda-observations-pithampur\/#Rubicon_Research_Share_Price_and_Recent_Performance\" title=\"Rubicon Research Share Price and Recent Performance\">Rubicon Research Share Price and Recent Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-usfda-observations-pithampur\/#What_This_Inspection_Means_for_Rubicon_Research\" title=\"What This Inspection Means for Rubicon Research\">What This Inspection Means for Rubicon Research<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-usfda-observations-pithampur\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-usfda-observations-pithampur\/#Frequently_Asked_Questions_on_Rubicon_Research_Share_Price\" title=\"Frequently Asked Questions on Rubicon Research Share Price\">Frequently Asked Questions on Rubicon Research Share Price<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-usfda-observations-pithampur\/#Why_did_Rubicon_Research_share_price_rise_despite_the_USFDA_observations\" title=\"Why did Rubicon Research share price rise despite the USFDA observations?\">Why did Rubicon Research share price rise despite the USFDA observations?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-usfda-observations-pithampur\/#What_did_the_USFDA_find_at_Rubicon_Researchs_Pithampur_plant\" title=\"What did the USFDA find at Rubicon Research&#8217;s Pithampur plant?\">What did the USFDA find at Rubicon Research&#8217;s Pithampur plant?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-usfda-observations-pithampur\/#What_is_a_USFDA_Form_483\" title=\"What is a USFDA Form 483?\">What is a USFDA Form 483?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-usfda-observations-pithampur\/#Is_a_Form_483_with_two_observations_a_serious_issue\" title=\"Is a Form 483 with two observations a serious issue?\">Is a Form 483 with two observations a serious issue?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-usfda-observations-pithampur\/#What_was_Rubicon_Research_share_price_on_6_July_2026\" title=\"What was Rubicon Research share price on 6 July 2026?\">What was Rubicon Research share price on 6 July 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-share-price-usfda-observations-pithampur\/#Is_Rubicon_Research_share_price_a_buy_after_this_USFDA_inspection\" title=\"Is Rubicon Research share price a buy after this USFDA inspection?\">Is Rubicon Research share price a buy after this USFDA inspection?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"About_Rubicon_Research\"><\/span><strong>About Rubicon Research<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Rubicon Research is a pharmaceutical company focused on the development and manufacturing of complex generic and specialty pharmaceutical products, with a manufacturing presence in India serving regulated markets including the United States.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Rubicon_Research_Share_Price_Is_in_Focus_Today\"><\/span><strong>Why Rubicon Research Share Price Is in Focus Today<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Rubicon Research share price is in focus because a USFDA inspection outcome is a closely watched event for any pharmaceutical company with US regulated manufacturing facilities, given the potential implications for future product approvals from the inspected site. Investors tracking Rubicon Research share price can view live quotes and fundamentals on the <a href=\"https:\/\/univest.in\/stocks\/rubicon\/rubicon-research-limited-share-price-today\">Univest stock page for Rubicon Research<\/a> before assessing the inspection outcome.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Details_of_the_USFDA_Inspection\"><\/span><strong>Details of the USFDA Inspection<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The USFDA conducted an unannounced inspection of Rubicon Research&#8217;s manufacturing facility at Pithampur, Madhya Pradesh, over a five day period from 29 June to 3 July 2026. Unannounced inspections are a standard part of the USFDA&#8217;s oversight process for facilities manufacturing products for the US market, and can occur without advance notice to the company.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Form_483_With_Two_Observations\"><\/span><strong>Form 483 With Two Observations<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Following the inspection, the USFDA issued Form 483 to Rubicon Research with two observations. A Form 483 lists conditions that FDA investigators believe may violate the Food, Drug and Cosmetic Act, and companies are typically given an opportunity to respond with corrective action plans before any further regulatory action, such as a Warning Letter, would follow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Rubicon_Research_USFDA_Inspection_Details\"><\/span><strong>Rubicon Research USFDA Inspection Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below summarises the key details of the inspection.<\/p>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Detail<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>Facility<\/td>\n<td>Pithampur, Madhya Pradesh<\/td>\n<\/tr>\n<tr>\n<td>Inspection Type<\/td>\n<td>Unannounced<\/td>\n<\/tr>\n<tr>\n<td>Inspection Period<\/td>\n<td>29 June to 3 July 2026<\/td>\n<\/tr>\n<tr>\n<td>Outcome<\/td>\n<td>Form 483 with two observations<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/sebi-registered-investment-advisor-india\"><strong>Talk to a SEBI Registered Investment Advisor on Univest<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Rubicon_Research_Share_Price_and_Recent_Performance\"><\/span><strong>Rubicon Research Share Price and Recent Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Rubicon Research share price touched an intraday high of Rs 1,392.90 and a low of Rs 1,333.15 during the session, with the stock&#8217;s gain despite the USFDA observations suggesting the market views a two-observation Form 483 as a relatively routine outcome rather than a signal of serious compliance concerns at the facility.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Rubicon Research share price live and get daily pharma sector research.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_This_Inspection_Means_for_Rubicon_Research\"><\/span><strong>What This Inspection Means for Rubicon Research<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Two observations on a Form 483 is generally considered a manageable outcome in the pharmaceutical industry, particularly compared to inspections that result in more numerous or serious findings. The company will typically need to respond to the USFDA with a corrective action plan within a defined timeframe, and the ultimate resolution will depend on how the regulator assesses the adequacy of that response. Investors should watch for the company&#8217;s official response and any further regulatory correspondence for confirmation that the matter is being resolved satisfactorily.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Rubicon Research share price rose over 5 percent on 6 July 2026 even after USFDA issued two observations following an inspection of its Pithampur manufacturing facility conducted between 29 June and 3 July. The stock was trading around Rs 1,370.80 during the session. Track the company&#8217;s response to the observations and consult a SEBI registered advisor before making any investment decision.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Rubicon_Research_Share_Price\"><\/span><strong>Frequently Asked Questions on Rubicon Research Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Rubicon_Research_share_price_rise_despite_the_USFDA_observations\"><\/span><strong>Why did Rubicon Research share price rise despite the USFDA observations?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Rubicon Research share price rose over 5 percent on 6 July 2026 as investors appeared to view the two observations issued by USFDA following the Pithampur plant inspection as a manageable outcome rather than a serious compliance concern.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_did_the_USFDA_find_at_Rubicon_Researchs_Pithampur_plant\"><\/span><strong>What did the USFDA find at Rubicon Research&#8217;s Pithampur plant?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The USFDA conducted an unannounced inspection of Rubicon Research&#8217;s Pithampur, Madhya Pradesh facility from 29 June to 3 July 2026, and issued Form 483 with two observations following the inspection.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_a_USFDA_Form_483\"><\/span><strong>What is a USFDA Form 483?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> A Form 483 is a notification issued by USFDA investigators listing conditions they believe may violate the Food, Drug and Cosmetic Act, giving the company an opportunity to respond with corrective actions before any further regulatory action.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_a_Form_483_with_two_observations_a_serious_issue\"><\/span><strong>Is a Form 483 with two observations a serious issue?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Two observations is generally considered a relatively manageable outcome for a USFDA inspection, especially compared to inspections resulting in more numerous or severe findings, though the ultimate outcome depends on the company&#8217;s corrective response.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_Rubicon_Research_share_price_on_6_July_2026\"><\/span><strong>What was Rubicon Research share price on 6 July 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Rubicon Research share price was quoting at Rs 1,370.80, up 5.22 percent, after touching an intraday high of Rs 1,392.90 and a low of Rs 1,333.15.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Rubicon_Research_share_price_a_buy_after_this_USFDA_inspection\"><\/span><strong>Is Rubicon Research share price a buy after this USFDA inspection?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This article does not constitute investment advice. The final regulatory outcome depends on the company&#8217;s corrective action response. Review the company&#8217;s financials and consult a SEBI registered financial advisor before making any investment decision.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rubicon Research share price rose over 5% on 6 July 2026 even after USFDA issued two Form 483 observations following an inspection of the company&#8217;s Pithampur, Madhya Pradesh manufacturing plant.<\/p>\n","protected":false},"author":35,"featured_media":140876,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3930],"class_list":["post-140825","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-share-price-rises"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1783327068:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["78"],"rank_math_title":["Rubicon Research Share Price Rises Despite USFDA Observations"],"rank_math_description":["Rubicon Research share price rose over 5% on 6 July 2026 even after USFDA issued two Form 483 observations following an inspection of the company's Pithampur, Madhya Pradesh manufacturing plant."],"rank_math_focus_keyword":["Rubicon Research share price"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_thumbnail_id":["140876"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["23631"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/Rubicon-Research-Share-Price-Rises.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/140825","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=140825"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/140825\/revisions"}],"predecessor-version":[{"id":140878,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/140825\/revisions\/140878"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/140876"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=140825"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=140825"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=140825"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}